フォロー
Masaru Kato
Masaru Kato
確認したメール アドレス: med.hokudai.ac.jp - ホームページ
タイトル
引用先
引用先
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
11006*2021
A case of transfusion‐transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food‐borne route
K Matsubayashi, JH Kang, H Sakata, K Takahashi, M Shindo, M Kato, ...
Transfusion 48 (7), 1368-1375, 2008
3362008
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
K Otomo, T Atsumi, O Amengual, Y Fujieda, M Kato, K Oku, T Horita, ...
Arthritis & Rheumatism 64 (2), 504-512, 2012
2672012
Dual role of autophagy in stress‐induced cell death in rheumatoid arthritis synovial fibroblasts
M Kato, C Ospelt, RE Gay, S Gay, K Klein
Arthritis & rheumatology 66 (1), 40-48, 2014
1182014
Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome
Y Fujieda, T Atsumi, O Amengual, T Odani, K Otomo, M Kato, K Oku, ...
Lupus 21 (14), 1506-1514, 2012
542012
Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases
M Kato, T Atsumi, T Kurita, T Odani, Y Fujieda, K Otomo, T Horita, ...
The Journal of Rheumatology 38 (10), 2209-2214, 2011
522011
Complement and thrombosis in the antiphospholipid syndrome
K Oku, H Nakamura, M Kono, K Ohmura, M Kato, T Bohgaki, T Horita, ...
Autoimmunity Reviews 15 (10), 1001-1004, 2016
512016
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results …
Y Kaneko, M Kato, Y Tanaka, M Inoo, H Kobayashi-Haraoka, K Amano, ...
Annals of the rheumatic diseases 77 (9), 1268-1275, 2018
422018
Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
R Hisada, M Kato, E Sugawara, Y Fujieda, K Oku, T Bohgaki, O Amengual, ...
Journal of thrombosis and haemostasis 15 (9), 1782-1787, 2017
422017
Long-term outcome in Japanese patients with lupus nephritis
M Kono, S Yasuda, M Kato, Y Kanetsuka, T Kurita, Y Fujieda, K Otomo, ...
Lupus 23 (11), 1124-1132, 2014
422014
Demographic, epidemiological, and virological characteristics of hepatitis E virus infections in Japan based on 254 human cases collected nationwide
T Abe, T Aikawa, Y Akahane, M Arai, Y Asahina, Y Atarashi, K Chayama, ...
Acta Hepatologica Japonica 47 (8), 384-391, 2006
412006
First‐Line, Non‐Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti–β2‐Glycoprotein I Domain …
H Nakamura, K Oku, O Amengual, K Ohmura, Y Fujieda, M Kato, ...
Arthritis Care & Research 70 (4), 627-634, 2018
372018
The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review
M Kato, H Kataoka, T Odani, Y Fujieda, K Otomo, K Oku, T Horita, ...
Lupus 20 (10), 1047-1056, 2011
352011
New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors
M Kato
Immunological Medicine 43 (2), 72-78, 2020
262020
Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin‐6 production in rheumatoid arthritis synovial fibroblasts
B Aradi, M Kato, M Filkova, E Karouzakis, K Klein, M Scharl, C Kolling, ...
Arthritis & Rheumatology 67 (10), 2624-2633, 2015
262015
Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus
Y Fujieda, H Kataoka, T Odani, K Otomo, M Kato, S Fukaya, K Oku, ...
Modern rheumatology 21 (3), 276-281, 2011
262011
Pulmonary arterial hypertension associated with connective tissue diseases: a review focusing on distinctive clinical aspects
M Kato, T Atsumi
European journal of clinical investigation 48 (2), e12876, 2018
232018
Significance of fully automated tests for the diagnosis of antiphospholipid syndrome
K Oku, O Amengual, M Kato, T Bohgaki, T Horita, S Yasuda, N Sakamoto, ...
Thrombosis Research 146, 1-6, 2016
222016
Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with …
Y Shimizu, S Yasuda, Y Kako, S Nakagawa, M Kanda, R Hisada, ...
Autoimmunity Reviews 15 (8), 786-794, 2016
212016
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome
N Ohnishi, Y Fujieda, R Hisada, H Nakamura, M Kato, K Oku, T Bohgaki, ...
Rheumatology 58 (6), 969-974, 2019
202019
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20